Abstract
The lymphoma classification currently in use, the fourth edition of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Swerdlow SH et al, (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, 2008), is founded on the basic principles of the Revised European American Lymphoma (REAL) Classification of 1994 (Harris NL et al, A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392, 1994). These principles, however, had been recognized earlier. Divergent and conflicting proposals for lymphoma classifications had been formulated in the 1970s, resulting in the emergence of two classification systems widely used: the Kiel classification of non-Hodgkin’s lymphomas (Stansfeld, et al, Updated Kiel classification for lymphomas. Lancet I: 292–293, 603, 1988) and the working formulation for clinical usage (WF; Non-Hodgkin’s lymphoma pathologic classification project 1982). Both classification systems relied upon entirely different principles. The Kiel classification was based on the exact morphological description and (later) immunological identification of the normal cellular counterparts of tumor cells and was updated several times.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alizadeh AA et al (2000) Distinct types of diffuse large cell lymphoma identified by gene expressing profiling. Nature 403:503–511
Aqel N et al (2008) In-situ mantle cell lymphoma—a report of two cases. Histopathology 52:256–260
Banks P et al (1992) Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637–640
Chan JK et al (2008) Extranodal NK/T cell lymphoma, nasal type. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Cong P et al (2002) In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99:3376–3382
Cremer T et al (1996) Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum Genet 74(4):346–352
Dave SS, Fu K, Wright GW et al (2006) Molecular diagnosis of Burkitt’s lymphoma. N Engl J Med 354:2431–2442
Davies RE et al (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463(7277):88–92
Döhner H et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343(26):1910–1915
Evans PA et al (2007) Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21(2):207–214
Finn L et al (1999) Primary follicular lymphoma of the testis in childhood. Cancer 85:1626–1635
Gaulard P et al (2008) Primary mediastinal (thymic) large B cell lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Gerdes J et al (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31(1):13–20
Golub TR et al (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286(5439):531–537
Haralambieva E et al (2005) Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 29:1086–1094
Harris NL et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392
Harris NL et al (2008) Follicular lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Henopp T et al (2011) Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 59(1):139–142
Horn H et al (2013) MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 121(12):2253–2263. doi: 10.1182/blood-2012-06-435842
Hummel M et al (2006) A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419–2430
Inghirami G et al (1993) Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin’s lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab Invest 68(6):746–757
Isaacson PG, Du MQ (2005) Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 205(2):255–274
Isaacson PG et al (2008) Enteropathy-associated T-cell lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Jaffe ES et al (2008) Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Johnson NA et al (2012) Concurrent expression of MYC and BCL2 in R-CHOP treated diffuse large B cell lymphoma. J Clin Oncol 30(28):3452–3459
Katzenberger T et al (2006) The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 107(8):3407
Katzenberger T et al (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113(5):1053–1061
Kluin PM et al (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Kneba M et al (1994) Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing. Blood 84(2):574–581
Lee MS et al (1987) The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas. Blood 70(1):90–95
Leich E et al (2009) Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 114(4):826–832
Leich E et al (2011) MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood 118(20):5550–5558
Lenz G et al (2008a) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359:2313–2323
Lenz G et al (2008b) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319(5870):1676–1679
Leoncini L et al (2008) Burkitt lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Limpens J et al (1991) Bcl-2 in benign lymphoid tissue with follicular hyperplasia. Oncogene 6:2271–2276
Lorsbach RB et al (2002) Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 99:1959–1964
Marti G et al (2007) Overview of monoclonal B-cell lymphocytosis. Br J Haematol 139:701–708
Mason DY et al (1994) Nodular lymphocyte predominance Hodgkin’s disease. A distinct clinicopathologic entity. Am J Surg Pathol 18:526–530
Mason DY et al (1998) Nuclear localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res 58:1057–1062
Müller-Hermelink HK, Greiner A (1998) Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. Am J Pathol 153:1341–1346
Ngo VN et al (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470(7332):115–119
Non-Hodgkin’ s Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. Cancer 49:2112–2135
Norton AJ et al (1994) Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173(4):371–379
Oshima K et al (2008) Adult T-cell leukaemia/lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Ott G et al (1997) The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin’s lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57(18):3944–3948
Oyama T et al (2003) Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16–26
Oyama T et al (2007) Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13:5124–5132
Pulford K et al (1997) Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89:1394–1404
Quintanilla-Martinez L et al (2008) EBV positive T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Rawstron AC et al (2002) Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 100:635–639
Rawstron AC et al (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359:575–583
Richard P et al (2006) “In situ-like” mantle cell lymphoma: a report of two cases. J Clin Pathol 59:995–996
Rosenwald A et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937–1947
Rosenwald A et al (2003a) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198(6):851–856
Rosenwald A et al (2003b) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3(2):185–197
Roulland S et al (2006) Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 203:2425–2431
Savage KJ et al (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102(12):3871–3879
Shi SR et al (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39(6):741–748
Shipp MA et al (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329:987–994
Stansfeld AG et al (1988) Updated Kiel classification for lymphomas. Lancet I:292–293 and 603
Streubel B et al (2004) Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18(10):1722–1726
Swerdlow SH et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon
Taddesse-Heath L et al (2003) Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 27:522–531
Taylor CR et al (1994) Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 25(3):263–270
The Non-Hodgkin’s Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 89:3909–391818
Traverse-Glehen A et al (2005) Mediastinal gray zone lymphoma: the missing link between classical Hodgkin’s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 29:1411–1421
Van Krieken JH et al (2007) Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21(2):201–206
Ventura RA et al (2006) FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8(2):141–151
Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma—an entity comes of age. Blood 87(11):4483–4494
Acknowledgement
The expert technical assistance of Mrs. Elisabeth Ott is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ott, G., Hsi, E.D., Delabie, J., Rodig, S. (2014). Principles of the Pathology and Biology of Malignant Lymphomas. In: Dreyling, M., Williams, M. (eds) Rare Lymphomas. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39590-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-39590-1_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39589-5
Online ISBN: 978-3-642-39590-1
eBook Packages: MedicineMedicine (R0)